Exicure (XCUR) EPS (Weighted Average and Diluted) (2019 - 2026)
Exicure (XCUR) reported EPS (Weighted Average and Diluted) of -$0.29 for Q1 2026, down 159.18% on a YoY basis from $0.49 in Q1 2025, and up 36.96% quarter-over-quarter from -$0.46 in Q4 2025.
Exicure (XCUR) EPS (Weighted Average and Diluted) (2019 - 2026) Analysis & Trends
Exicure has reported EPS (Weighted Average and Diluted) for 8 years, with the latest figure at -$0.29 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Weighted Average and Diluted) fell 159.18% year-over-year to -$0.29; the trailing twelve-month figure through Mar 2026 stood at -$1.55 (up 59.42% YoY), and the FY2025 full-year result was -$0.79, up 83.37% from the prior year.
- EPS (Weighted Average and Diluted) for Q1 2026 stood at -$0.29, up from -$0.46 in the prior quarter.
- The five-year high for EPS (Weighted Average and Diluted) was $4.1 in Q4 2022, with the low at -$3.39 in Q4 2024.
- Historically, EPS (Weighted Average and Diluted) has averaged -$0.68 across 5 years, with a median of -$0.57 in 2024.
- Annual changes were most pronounced in 2022 — EPS (Weighted Average and Diluted) plunged 1378.57% — and 2025, when it surged 202.08%.
- Exicure's EPS (Weighted Average and Diluted) stood at $4.1 in 2022, then slumped by 116.1% to -$0.66 in 2023, then slumped by 413.64% to -$3.39 in 2024, then surged by 86.43% to -$0.46 in 2025, then jumped by 36.96% to -$0.29 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.29 (Q1 2026), -$0.46 (Q4 2025), and -$0.39 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 0.68 |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 3.06 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 3,086.42 |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 0.00 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 4.02 |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -0.61 |
| 10 | Exicure | 19.38 Mn | 16.77 Mn | - | -0.29 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.29 |
| Dec 31, 2025 | -0.46 |
| Sep 30, 2025 | -0.39 |
| Jun 30, 2025 | -0.41 |
| Mar 31, 2025 | 0.49 |
| Dec 31, 2024 | -3.39 |
| Sep 30, 2024 | -0.57 |
| Jun 30, 2024 | -0.35 |
| Mar 31, 2024 | -0.48 |
| Dec 31, 2023 | -0.66 |
| Sep 30, 2023 | -3.04 |
| Jun 30, 2023 | -0.68 |
| Mar 31, 2023 | -0.70 |
| Dec 31, 2022 | 4.10 |
| Sep 30, 2022 | -1.04 |
| Jun 30, 2022 | -1.66 |
| Mar 31, 2022 | -2.07 |
| Dec 31, 2021 | -4.56 |
| Sep 30, 2021 | -8.01 |
| Jun 30, 2021 | -4.86 |